Can You Restart Vyvanse 50 mg Daily and Intuniv 3 mg Daily After a 5-Day Break?
Yes, you can restart both medications, but Intuniv (guanfacine) 3 mg should be restarted at a lower dose and retitrated, while Vyvanse (lisdexamfetamine) 50 mg can typically be resumed at the full dose if previously well-tolerated.
Intuniv (Guanfacine Extended-Release) Restart Protocol
The FDA label for Intuniv provides explicit guidance on missed doses: when reinitiating patients to the previous maintenance dose after two or more missed consecutive doses, physicians should consider titration based on patient tolerability 1. After 5 days off a 3 mg dose, you have missed more than two consecutive doses.
Recommended Restart Approach for Intuniv:
- Do not restart at 3 mg directly after a 5-day interruption
- Begin at 1 mg daily and retitrate upward by no more than 1 mg per week 1
- This prevents cardiovascular adverse effects (hypotension, bradycardia, excessive sedation) that are dose-related and exposure-related 1
- The gradual retitration typically takes 2-3 weeks to return to your maintenance dose of 3 mg
Why Retitration Matters:
Guanfacine's cardiovascular effects require physiologic adaptation. After 5 days without medication, your body has lost tolerance to the alpha-2 adrenergic effects. Research demonstrates that abrupt reintroduction at full doses can cause problematic sedation and cardiovascular changes 2. While abrupt discontinuation of guanfacine does not typically cause severe rebound hypertension (unlike clonidine), the reverse situation—abrupt reintroduction—carries risks of excessive hypotension and sedation 3, 4.
Clinical evidence shows that somnolence is a major reason for early guanfacine discontinuation, particularly in the first 70 days of treatment and especially when used as monotherapy 4. Restarting at full dose after a break essentially resets this risk window.
Vyvanse (Lisdexamfetamine) Restart Protocol
For Vyvanse, the situation is more straightforward. Stimulant medications like lisdexamfetamine do not require retitration after short interruptions if the medication was previously well-tolerated 5, 6.
Recommended Restart Approach for Vyvanse:
- Resume at your previous dose of 50 mg daily if you tolerated it well before the break
- Take in the morning to minimize insomnia risk
- Monitor for typical stimulant side effects (appetite suppression, sleep disturbance, cardiovascular changes)
Supporting Rationale:
Unlike guanfacine, stimulants do not cause physiologic dependence requiring dose tapering or retitration. The ADHD treatment guidelines do not specify retitration requirements for stimulants after brief interruptions 5, 6. The primary concern with stimulants is diversion and misuse potential, not physiologic tolerance requiring dose adjustment after short breaks 5.
Practical Implementation Algorithm
Day 1-7:
- Start Intuniv 1 mg once daily (morning or evening, same time each day)
- Resume Vyvanse 50 mg once daily in the morning
- Monitor blood pressure and heart rate if possible
- Watch for excessive sedation, dizziness, or fatigue
Day 8-14:
- Increase Intuniv to 2 mg once daily
- Continue Vyvanse 50 mg daily
- Continue monitoring for sedation and cardiovascular effects
Day 15-21:
- Increase Intuniv to 3 mg once daily (your target maintenance dose)
- Continue Vyvanse 50 mg daily
- Assess ADHD symptom control and tolerability
Important Safety Considerations
Cardiovascular Monitoring:
Both medications affect cardiovascular parameters. Guanfacine can cause hypotension and bradycardia, while lisdexamfetamine can cause hypertension and tachycardia 6, 1. The combination may have offsetting effects, but individual responses vary. If you have any cardiac history or symptoms, obtain baseline vital signs before restarting.
Sedation Management:
The most common reason patients discontinue guanfacine early is somnolence 4. The combination of a stimulant (Vyvanse) with guanfacine may actually help mitigate guanfacine-related sedation 4, which is one reason this combination is FDA-approved for adjunctive use 1.
Avoid High-Fat Meals with Intuniv:
Take Intuniv without high-fat meals, as they significantly increase drug exposure 1. Swallow tablets whole—do not crush, chew, or break them.
Common Pitfalls to Avoid
Do not restart Intuniv at 3 mg after a 5-day break—this is the most critical error to avoid and contradicts FDA labeling 1
Do not abruptly stop Intuniv again once restarted—if you need to discontinue in the future, taper by no more than 1 mg every 3-7 days to minimize rebound blood pressure elevation 1
Do not assume you need to retitrate Vyvanse—this is unnecessary for stimulants after brief interruptions in previously stable patients
Do not ignore cardiovascular symptoms—dizziness, lightheadedness, syncope, or palpitations warrant immediate medical evaluation
The evidence strongly supports this differentiated approach: careful retitration for guanfacine based on FDA labeling and pharmacologic principles 1, while resuming stimulants at the previous effective dose based on ADHD treatment guidelines 5, 6.